Blood Cancer News

Another exploration from QIMR Berghofer has recognized an early hereditary change in blood and bone marrow cells makes ready for the improvement of some blood malignant growths.

The disclosure gives another objective to the treatment of the blood malignancies myelodysplastic condition (MDS) and intense myeloid leukemia (AML). MDS is regularly a forerunner malignancy to AML, an exceptionally forceful type of leukemia.

The examination discoveries have been distributed in the esteemed worldwide diary Nature Communications.

Lead scientist and the head of QIMR Berghofer Medical Research Institute's Cancer Program, Associate Professor Steven Lane, said his group built the translation factor Cdx2 into ordinary mouse platelets, and this brought about the improvement of MDS and AML.

High Impact List of Articles

Reduction of frequency of pain in clinical trial with association of arginine and hydroxyurea in sickle cell anemia's patients in Brazil
Renata EleutÃ©rio
Commentary: Hematology and Blood Disorders
Reduction of frequency of pain in clinical trial with association of arginine and hydroxyurea in sickle cell anemia's patients in Brazil
Renata EleutÃ©rio
Commentary: Hematology and Blood Disorders
Breakthrough notions in Hematology and Transfusion Medicine: Market Scrutiny
Shimon Slavin
Market Analysis: Hematology and Blood Disorders
Breakthrough notions in Hematology and Transfusion Medicine: Market Scrutiny
Shimon Slavin
Market Analysis: Hematology and Blood Disorders
Comparing methods of tranexamic acid administration and blood reinfusion in reducing blood loss during total knee arthroplasty.
Mingyang Yu, Bowu Luan, Simiao Tian, Guishan Gu
Research Article: Hematology and Blood Disorders
Comparing methods of tranexamic acid administration and blood reinfusion in reducing blood loss during total knee arthroplasty.
Mingyang Yu, Bowu Luan, Simiao Tian, Guishan Gu
Research Article: Hematology and Blood Disorders
Myelodysplastic syndromes and elderly patients.
Roberto Castelli, Luigi Bergamaschini
Perspective: Hematology and Blood Disorders
Myelodysplastic syndromes and elderly patients.
Roberto Castelli, Luigi Bergamaschini
Perspective: Hematology and Blood Disorders
Next-generation sequencing: emerging technology in the area of hematology and blood disorder.
Prabhakar S Kedar
Short Communication: Hematology and Blood Disorders
Next-generation sequencing: emerging technology in the area of hematology and blood disorder.
Prabhakar S Kedar
Short Communication: Hematology and Blood Disorders

Conference Proceedings

TRIGGER POINTS TREATMENT IN SOCCER PLAYERS: AN INTEGRATIVE REVIEW
Leonardo Kenji Nakamura
Posters & Accepted Abstracts: Asian Journal of Biomedical and Pharmaceutical Sciences
TRIGGER POINTS TREATMENT IN SOCCER PLAYERS: AN INTEGRATIVE REVIEW
Leonardo Kenji Nakamura
Posters & Accepted Abstracts: Asian Journal of Biomedical and Pharmaceutical Sciences
Potential use of photobiomodulation in stem cell therapy
Heidi Abrahamse
Scientific Tracks Abstracts: Biomedical Research
Potential use of photobiomodulation in stem cell therapy
Heidi Abrahamse
Scientific Tracks Abstracts: Biomedical Research
Catalytic oxidative cracking of light alkanes to alkenes: A review
Boyadjian C
Posters & Accepted Abstracts: Asian Journal of Biomedical and Pharmaceutical Sciences
Catalytic oxidative cracking of light alkanes to alkenes: A review
Boyadjian C
Posters & Accepted Abstracts: Asian Journal of Biomedical and Pharmaceutical Sciences
A NOVEL APPROACH TO OBESITY MANAGEMENT AN ECONOMICAL, PATIENT PARTICIPATION STUDY FOR MULTIPLE DISEASES PREVENTION
Vinod Chandra Tawar
Scientific Tracks Abstracts: Archives of General Internal Medicine
A NOVEL APPROACH TO OBESITY MANAGEMENT AN ECONOMICAL, PATIENT PARTICIPATION STUDY FOR MULTIPLE DISEASES PREVENTION
Vinod Chandra Tawar
Scientific Tracks Abstracts: Archives of General Internal Medicine
DRUG RESISTANT STEM CELLS: MODELS FOR TARGETED THERAPY OF BREAST CANCER
Nitin Telang
Scientific Tracks Abstracts: Journal of Medical Oncology and Therapeutics
DRUG RESISTANT STEM CELLS: MODELS FOR TARGETED THERAPY OF BREAST CANCER
Nitin Telang
Scientific Tracks Abstracts: Journal of Medical Oncology and Therapeutics